Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.! Big Pharma's Latest Move: Acquisition Unlocks $15 Million Market Opportunity in the U.S.! Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market DSIJ Intelligence / Monday, March 3, 2025 / Article rating: 5.0 Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market
Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent The company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey DSIJ Intelligence / Monday, February 24, 2025 / Article rating: 4.5 The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market! DSIJ Intelligence / Friday, February 14, 2025 / Article rating: 3.3 FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!
This Small-Cap Pharma Stock is Up 6 per cent! Lands Major Orders from 3 Countries! This Small-Cap Pharma Stock is Up 6 per cent! Lands Major Orders from 3 Countries! A leading player in personal protection and healthcare products expands its international footprint DSIJ Intelligence / Thursday, February 13, 2025 / Article rating: 5.0 A leading player in personal protection and healthcare products expands its international footprint
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance DSIJ Intelligence / Tuesday, January 7, 2025 / Article rating: 5.0 FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. DSIJ Intelligence / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence DSIJ Intelligence / Monday, November 11, 2024 / Article rating: 5.0 With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence
This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams DSIJ Intelligence / Wednesday, November 6, 2024 / Article rating: 3.8 Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Sensex Dips While Mid & Small-Caps Shine Bright! Sensex Dips While Mid & Small-Caps Shine Bright! Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform DSIJ Intelligence / Tuesday, September 3, 2024 / Article rating: No rating Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform
Midday Market Mix: Sensex & Nifty Slip, But Midcaps & Smallcaps Shine Bright! Midday Market Mix: Sensex & Nifty Slip, But Midcaps & Smallcaps Shine Bright! Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive DSIJ Intelligence / Tuesday, September 3, 2024 / Article rating: No rating Pharma, Consumer Durables Lead Gains as Bajaj Finance & Adani Ports Drag; Market Breadth Stays Positive